EPI Pipeline
Aug 24, 2020
What Can Help Manage The Insufficient Pancreas?
The launch of the Pipeline therapies, increasing EPI prevalence shall fuel the Exocrine pancreatic insufficiency market size estimated to be approximately USD 1,695.26 Million in 2017. A loss of acinar pancreatic cells that causes insufficient production of pancreatic enzymes in the duodenum results in Exo...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
